Hepatotoxicity with low- and ultralow-dose flutamide: A surveillance study on 203 hyperandrogenic young females

Fertility and Sterility

Volumn 98, Issue 4, 2012, Pages 1047-1052

  Bruni, Vincenzina ^a   Peruzzi, Elena ^a   Dei, Metella ^a   Nannini, Sara ^a   Seravalli, Viola ^a   Sisti, Giovanni ^a   Fambrini, Massimiliano ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Flutamide; hepatotoxicity; hyperandrogenism

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; DESOGESTREL; ETHINYLESTRADIOL; FLUTAMIDE; GESTODENE;

ADOLESCENT; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; CONTROLLED STUDY; DRUG WITHDRAWAL; FEMALE; HUMAN; HYPERANDROGENISM; HYPERTRANSAMINASEMIA; LIVER FUNCTION; LIVER TOXICITY; LOW DRUG DOSE; MAJOR CLINICAL STUDY; ORAL CONTRACEPTION; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ALANINE TRANSAMINASE; ANDROGEN ANTAGONISTS; ASPARTATE AMINOTRANSFERASES; BIOLOGICAL MARKERS; CONTRACEPTIVES, ORAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; DRUG-INDUCED LIVER INJURY; ETHINYL ESTRADIOL; FEMALE; FLUTAMIDE; HUMANS; HYPERANDROGENISM; NORPREGNENES; POPULATION SURVEILLANCE; RISK FACTORS; YOUNG ADULT;

EID: 84867028378     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2012.06.018     Document Type: Article

References (34)

1. R.J. Norman, D. Dewailly, R.S. Legro, and T.E. Hickey Polycystic ovary syndrome Lancet 370 2007 685 697
2. R.L. Rosenfield Clinical practice. Hirsutism N Engl J Med 353 2005 2578 2588
3. B.R. Goldspiel, and D.R. Kohler Flutamide: an antiandrogen for advanced prostate cancer DICP 24 1990 616 623
4. F. Fruzzetti, D. De Lorenzo, C. Ricci, and P. Fioretti Clinical and endocrine effects of flutamide in hyperandrogenic women Fertil Steril 60 1993 806 813
5. Müderris II, F. Bayram, Y. Sahin, F. Keleştimur, A. Tutuş, and D. Ayata The efficacy of 250 mg/day flutamide in the treatment of patients with hirsutism Fertil Steril 66 1996 220 222
6. S. Venturoli, O. Marescalchi, F.M. Colombo, S. Macrelli, B. Ravaioli, and A. Bagnoli A prospective randomized trial comparing low dose flutamide, finasteride, ketoconazole, and cyproterone acetate-estrogen regimens in the treatment of hirsutism J Clin Endocrinol Metab 84 1999 1304 1310
7. S. Venturoli, R. Paradisi, A. Bagnoli, F.M. Colombo, B. Ravaioli, and F. Vianello Low-dose flutamide (125 mg/day) as maintenance therapy in the treatment of hirsutism Horm Res 56 2001 25 31
8. A. Gambineri, C. Pelusi, S. Genghini, A.M. Morselli-Labate, M. Cacciari, and U. Pagotto Effect of flutamide and metformin administered alone or in combination in dieting obese women with polycystic ovary syndrome Clin Endocrinol (Oxf) 60 2004 241 249
9. C. Castelo-Branco, and M. Del Pino Hepatotoxicity during low-dose flutamide treatment for hirsutism Gynecol Endocrinol 25 2009 419 422
10. Z. Thole, G. Manso, E. Salgueiro, P. Revuelta, and A. Hidalgo Hepatotoxicity induced by antiandrogens: a review of the literature Urol Int 73 2004 289 295
11. C. Wallace, E.A. Lalor, and C.L. Chik Hepatotoxicity complicating flutamide treatment of hirsutism Ann Intern Med 119 1993 1150
12. D.K. Wysowski, J.P. Freiman, J.B. Tourtelot, and M.L. Horton 3rd Fatal and nonfatal hepatotoxicity associated with flutamide Ann Intern Med 118 1993 860 864
13. D.K. Wysowski, and J.L. Fourcroy Flutamide hepatotoxicity J Urol 155 1996 209 212
14. R.J. Andrade, M.I. Lucena, M.C. Fernández, F. Suárez, J.L. Montero, and E. Fraga Fulminant liver failure associated with flutamide therapy for hirsutism Lancet 353 1999 983
15. J.L. Gomez, A. Dupont, L. Cusan, M. Tremblay, R. Suburu, and M. Lemay Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients Am J Med 92 1992 465 470
16. Müderris II, F. Bayram, and M. Güven Treatment of hirsutism with lowest-dose flutamide (62.5 mg/day) Gynecol Endocrinol 14 2000 38 41
17. L. Ibáñez, and F. De Zegher Flutamide-metformin plus an oral contraceptive (OC) for young women with polycystic ovary syndrome: switch from third- to fourth-generation OC reduces body adiposity Hum Reprod 19 2004 1725 1727
18. L. Ibáñez, A. Jaramillo, A. Ferrer, and F. de Zegher Absence of hepatotoxicity after long-term, low-dose flutamide in hyperandrogenic girls and young women Hum Reprod 20 2005 1833 1836
19. E. Dikensoy, O. Balat, S. Pence, C. Akcali, and H. Cicek The risk of hepatotoxicity during long-term and low-dose flutamide treatment in hirsutism Arch Gynecol Obstet 279 2009 321 327
20. D. Ferriman, and J.D. Gallwey Clinical assessment of body hair growth in women J Clin Endocrinol Metab 21 1961 1440 1447
21. A. Doshi, A. Zaheer, and M.J. Stiller A comparison of current acne grading system and proposal of novel system Int Dermatol 36 1997 416 418
22. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome Fertil Steril 81 2004 19 25
23. J. Collier, and M. Bassendine How to respond to abnormal liver function tests Clin Med 2 2002 406 409
24. M.C. Kew Serum aminotransferase concentration as evidence of hepatocellular damage Lancet 355 2000 591 592
25. F. de Zegher, and L. Ibáñez Flutamide for androgen excess: low dose is best J Pediatr Adolesc Gynecol 24 2011 e43 e44
26. Y. Nakagawa, M. Koyama, and M. Matsumoto Flutamide-induced hepatic disorder and serum concentrations of Flutamide and its metabolites in patients with prostate cancer Hinyokika Kiyo 45 1999 821 826
27. T. Wada, M. Ueda, K. Abe, T. Kobari, H. Yamazaki, and J. Nakata Risk factor of liver disorders caused by flutamide - statistical analysis using multivariate logistic regression analysis Hinyokika Kiyo 45 1990 521 526
28. Y. Matsuzaki, D. Nagai, E. Ichimura, R. Goda, A. Tomura, and M. Doi Metabolism and hepatic toxicity of flutamide in cytochrome P450 1A2 knockout SV129 mice J Gastroenterol 41 2006 231 239
29. A. Watanabe, T. Fukami, M. Nakajima, M. Takamiya, Y. Aoki, and T. Yokoi Human arylacetamide deacetylase is a principal enzyme in flutamide hydrolysis Drug Metab Dispos 37 2009 1513 1520
30. B. Wang, and S.F. Zhou Synthetic and natural compounds that interact with human cytochrome P450 1A2 and implications in drug development Curr Med Chem 16 2009 4066 4218
31. A. Gunes, and M.L. Dahl Variation in CYP1A2 activity and its clinical implications: influence of environmental factors and genetic polymorphisms Pharmacogenomics 9 2008 625 637
32. Y. Kobayashi, T. Fukami, A. Nakajima, A. Watanabe, M. Nakajima, and T. Yokoi Species differences in tissue distribution and enzyme activities of arylacetamide deacetylase in human, rat, and mouse Drug Metab Dispos 40 2012 671 679
33. J. Brahm, M. Brahm, R. Segovia, R. Latorre, R. Zapata, and J. Poniachik Acute and fulminant hepatitis induced by flutamide: case series report and review of the literature Ann Hepatol 10 2011 93 98
34. B.W. Smith, and L.A. Adams Non-alcoholic fatty liver disease Crit Rev Clin Lab Sci 48 2011 97 113